FDA Grants Bright Path AMT Designation as It Moves to Reshore America's Medicines and Reduce Reliance on China
The designation covers Bright Path's end-to-end U.S. production of two hospital medicines in chronic shortage, the first proof that essential medicines can be made in America, in most cases at prices that beat China and India MESA, Ariz., Sept. 14, 2026 /PRNewswire/ -- Bright Path, a U.S....
Covered in this story
What has happened since
- American Tower is up 3.7% since this was published, 36 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $AMT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on American Tower →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.